Current neural induction protocols for human embryonic stem (hES) cells rely on embryoid body formation, stromal feeder co-culture or selective survival conditions. Each strategy has considerable drawbacks, such as poorly defined culture conditions, protracted differentiation and low yield. Here we report that the synergistic action of two inhibitors of SMAD signaling, Noggin and SB431542, is sufficient to induce rapid and complete neural conversion of 480% of hES cells under adherent culture conditions. Temporal fate analysis reveals the appearance of a transient FGF5 + epiblast-like stage followed by PAX6 + neural cells competent to form rosettes. Initial cell density determines the ratio of central nervous system and neural crest progeny. Directed differentiation of human induced pluripotent stem (hiPS) cells into midbrain dopamine and spinal motoneurons confirms the robustness and general applicability of the induction protocol. Noggin/SB431542-based neural induction should facilitate the use of hES and hiPS cells in regenerative medicine and disease modeling and obviate the need for protocols based on stromal feeders or embryoid bodies.
Current neural induction protocols for human embryonic stem (hES) cells rely on embryoid body formation, stromal feeder co-culture or selective survival conditions. Each strategy has considerable drawbacks, such as poorly defined culture conditions, protracted differentiation and low yield. Here we report that the synergistic action of two inhibitors of SMAD signaling, Noggin and SB431542, is sufficient to induce rapid and complete neural conversion of 480% of hES cells under adherent culture conditions. Temporal fate analysis reveals the appearance of a transient FGF5 + epiblast-like stage followed by PAX6 + neural cells competent to form rosettes. Initial cell density determines the ratio of central nervous system and neural crest progeny. Directed differentiation of human induced pluripotent stem (hiPS) cells into midbrain dopamine and spinal motoneurons confirms the robustness and general applicability of the induction protocol. Noggin/SB431542-based neural induction should facilitate the use of hES and hiPS cells in regenerative medicine and disease modeling and obviate the need for protocols based on stromal feeders or embryoid bodies.
HES cells offer great promise for cell-replacement therapies, and recent advances in somatic cell reprogramming to iPS cells have opened the door to generating patient-specific cells for regenerative medicine and disease modeling 1 . To realize the full potential of these approaches for the production of neural cells, improved differentiation protocols are required that eliminate the use of undefined factors (such as neuralinducing stroma PA6 or MS5 cells 2, 3 ), the heterogeneous nature of embryoid body differentiation and the poor yield of protocols based on selective survival of neural progeny. Understanding and triggering the signaling pathways necessary and sufficient for neural induction in hES cells is a critical goal in this effort.
Several lines of evidence demonstrate a crucial role for SMAD signaling during neural induction. Elegant studies in frog identified bone morphogenic protein (BMP) inhibitors, including chordin 4 , follistatin 5 and noggin 6 , as the critical neural-inducing factors in the Spemann organizer. Mammalian noggin 7 has similar neural-inducing properties, and treatment with recombinant Noggin has been used in several hES-cell neural induction protocols 3, 8 . More recently, the drug SB431542 was shown to enhance neural induction in an embryoid body-based hES-cell neural induction protocol 9 . SB431542 inhibits the Lefty/Activin/TGFb pathways by blocking phosphorylation of the ALK4, ALK5 and ALK7 receptors. Although Noggin or SB431542 treatment improve the efficiency of neural induction, neither treatment alone is sufficient to neurally convert hES cells under defined or adherent conditions. Here we set out to test whether combined blockade of SMAD signaling using Noggin and SB431542 is sufficient to achieve full neural conversion and to avoid the use of embryoid bodies or stromal feeders.
We postulated that establishing an even cell distribution is critical for inducing homogeneous neural differentiation of hES cells. Therefore, undifferentiated hES cells were dissociated into single cells and replated onto Matrigel-coated dishes in conditioned medium supplemented with the ROCK inhibitor Y-27632 10 , which promotes survival of hES cells as single cells. After 72 h, cells were switched from hES-cell conditions to knockout serum replacement medium containing either Noggin, SB431542 or both factors and allowed to differentiate for a total of 11 d (Fig. 1a) . Perinuclear redistribution of SMAD4, the obligate co-SMAD, was observed after 24 h when both Noggin and SB431542 were present ( Supplementary Fig. 1 online) . Neural induction was monitored by expression of PAX6, an early marker of neuroectodermal differentiation 11 . Combined treatment with Noggin and SB431542 greatly increased the efficiency of neural induction to 480% of total cells, compared with o10% PAX6 + cells when Noggin or SB431542 were used alone (Fig. 1b) .
There are several potential mechanisms that could contribute to the synergistic action of Noggin and SB431542. These include destabilizing the activin-and Nanog-mediated pluripotency network 12 , suppression of BMP-induced differentiation toward trophoblast lineage 13 , suppression of mesodermal and endodermal fates by inhibiting endogenous activin and BMP signals 14, 15 , and promoting neuralization of primitive ectoderm by BMP inhibition 16 . Temporal analysis of gene expression revealed that treatment with SB431542 induced a rapid loss of Nanog expression ( Supplementary Fig. 2 online) and a large increase in the expression of CDX2 (Fig. 1c) . These data suggest that SB431542-mediated loss of pluripotency is associated with differentiation toward the trophoblast lineage. Suppression of CDX2 in the presence of Noggin or Noggin/SB431542 demonstrates that one © 2009 Nature America, Inc. All rights reserved.
key role of Noggin is the repression of endogenous BMP signals that drive trophoblast fates upon differentiation. The pronounced induction of SOX1 in Noggin/SB431542-treated cultures confirmed a strong bias toward neuroectodermal lineage in the dual-SMAD-inhibition protocol. There is also evidence for suppression of alternative embryonic germ layers, such as Noggin-mediated suppression of SOX17 (endodermal lineage) and SB431542-mediated suppression of Brachyury (mesodermal lineage) (Fig. 1c) . Taken together, these results indicate that SB431542 and Noggin work synergistically at multiple stages of differentiation to achieve efficient neural conversion of hES cells.
We next sought to characterize lineage progression of hES-cell progeny after the addition of the two inhibitors. Loss of OCT4 expression by day 5 and strong expression of PAX6 by day 7 (Fig. 1d) pointed to the presence of an intermediate cell type at day 5 of differentiation that was negative for both OCT4 and PAX6. Gene expression analysis revealed peak expression of the epiblast marker FGF5 at day 5 of differentiation, concomitant with high expression of OTX2, another epiblast marker whose expression is maintained during neural fate commitment (Fig. 1e) . The expression of OTX2 and FGF5 before neuralization suggests the presence of epiblast-stage cells in our cultures 17 . Notably, the earliest neural marker expressed in our culture system was SOX1 (Fig. 1f) , preceding induction of other neuroepithelial markers such as ZIC1 or PAX6 and preceding expression of anterior central nervous system (CNS; FOXG1) and neural crest (p75) markers. Whereas previous studies had suggested that PAX6 preceded SOX1 expression 18 , early induction of SOX1 has been observed in mouse cultures 19 . One interesting possibility to explain early SOX1 expression could be direct modulation of SOX1 transcription by SMAD signaling in our culture system. Our laboratory has recently described methods for establishing stable mouse 20 and hES-cell 21 transgenic reporter lines carrying bacterial artificial chromosomes (BACs) engineered to express GFP under the control of cell-type specific promoters. Here we used the HES5:eGFP BAC transgenic hES-cell reporter line, marking neural stem and precursor cell progeny 20, 21 , to measure the efficiency of neural induction. The dual-SMAD-inhibition protocol was compared to the standard MS5 protocol in the presence of Noggin 22 . To this end, HES5:eGFP cells were plated in medium supplemented with Noggin either in the presence of MS5 feeder cells or SB431542 and allowed to differentiate for 13 d, a stage when the GFP + cells were readily observed under both conditions (Supplementary Fig. 3 online) . GFP expression was quantified by flow cytometry. Nonmodified H9 cells were used as negative controls. MS5 cells were excluded from the analysis based on negative selection for the cell-surface molecule CD105 (Supplementary. Fig. 4 online). Dual-SMAD inhibition yielded 82% GFP + cells at day 13, a more than threefold increase compared with the MS5/Noggin protocol (Fig. 1g) . In contrast to the MS5 protocol, which requires plating of hES-cell colonies at low density in the presence of an MS5 mouse stromal cell line 22 , the Noggin/SB431542 condition allowed for high plating densities. Therefore, in addition to higher percentages, the dual-SMAD-inhibition protocol also resulted in larger absolute numbers of Hes5:eGFP + cells per culture plate (data not shown). We previously reported the isolation of rosette neural stem (R-NS) cells 8 and neural crest stem (NCS) cells 3 from hES cells. We next sought to determine the lineage relationship of the early PAX6 + neuroectodermal cells observed in the dual-SMAD-inhibition protocol to the R-NS and NCS cell populations described previously. Immunocytochemical analysis showed that, similar to R-NS cells, PAX6 + neuroectodermal cells express general neural stem cell markers, such as Nestin, and R-NS cell markers, including promyelocytic leukemia zinc finger (PLZF; Fig. 2a,b ; day 11 of differentiation). However, cytoarchitecture and ZO1 expression indicated that neuroepithelial cells under these conditions were nonpolarized, exhibiting a more primitive ES cell-like cytoarchitecture. These nonpolarized areas were interspersed with R-NS cell-like areas composed of polarized columnar epithelial cells (Fig. 2c) . The developmental hierarchy of these two cell populations was further explored upon subsequent passage. Early neuroepithelial cells spontaneously converted into rosette structures with apical ZO1 expression and evidence of interkinetic nuclear migration after cell passage (Fig. 2d) . These data suggest that the Noggin/SB431542 protocol yields an early PAX6 + neuroepithelial population capable of rosette formation. The early PAX6 + cells may therefore represent the most primitive hES cell-derived neural precursor stage isolated to date. R-NS cells have been shown to acquire anterior CNS markers by default 8 .
PAX6 + neuroepithelial cells generated by means of the dual-SMAD-inhibition protocol exhibited an anterior CNS character, as evidenced by expression of Otx2 and FoxG1B (Fig. 2e,f) , similar to R-NS cells 8 . Notably, PAX6 -cells under these conditions co-expressed markers of neural crest, including AP2, HNK1, PAX7 and p75 (NGFR) (Fig. 2g-j) . Manipulation of the initial hES-cell plating density skewed the ratio of PAX6 + CNS and PAX6 -neural crest-like cells. High plating densities resulted in near-exclusive differentiation toward PAX6 + cells, whereas low densities promoted neural crest-like differentiation ( Supplementary  Fig. 5 online) . The presence of large numbers of neural crest-like cells before rosette formation suggested that dual-SMAD inhibition yields an early neural crest population distinct from R-NS cell-derived NCS cells 3 . Supporting the notion of an early neural crest population with distinct lineage potential, cells could be readily enriched for pigmented cells co-expresssing the melanosome marker, HMB45 (Fig. 2k,l) . In contrast, R-NS cell-derived NCS cells typically do not yield pigmented cells under similar conditions 3 . However, not all HMB45 + cells coexpressed the neural crest marker SOX10, suggesting the presence of other pigmented cell populations, including retinal pigment epithelial cells arising from the PAX6 + domain (data not shown). It will be interesting in the future to compare differential fate potential of early versus R-NS cell-derived neural crest precursors in our hES-cell system with the fate potential of different neural crest precursor populations in vivo. Anterior-posterior and dorso-ventral identity and neuronal subtype potential are dependent on early exposure to morphogenic factors such as retinoic acid, FGF8 and SHH. We next explored the patterning potential of cells generated via the dual-SMAD-inhibition protocol. We postulated that day 5 of differentiation may present an appropriate developmental window for neural patterning as Oct4 expression is silenced between day 3 and 5, and the neural marker PAX6 is activated in the majority of cells between day 5 and 7 ( Fig. 1d,e) .
Derivation of cells expressing markers of dopamine neurons was observed after exposure to SHH and FGF8 (ref. 22 ) starting at day 5 and day 9 of differentiation, respectively (Fig. 2m) . One week after SHH exposure, both FGF8 and SHH were withdrawn, and cells further differentiated in medium containing BDNF, ascorbic acid, GDNF, TGF-b3 and cyclic-AMP (BAGTC 22 , see Fig. 2m ). At day 19 of differentiation, a large proportion of Tuj1 + neurons co-expressed tyrosine hydroxylase (TH) (Fig. 2n,o) , the rate-limiting enzyme in the synthesis of dopamine. TH + neurons emerged under these conditions spontaneously even in the absence of cell passaging. However, derivation of more mature TH + cells with long neural processes was promoted after mechanical isolation and en bloc passage at day 12 of differentiation ( Fig. 2p) .
Nuclear expression of the motoneuron markers ISL1 and HB9 was observed after 2 weeks of exposure to BDNF, ascorbic acid, SHH and retinoic acid (BASR; day 19 of differentiation), confirming the derivation of somatic type motoneurons (Fig. 2q,r) . Motoneuron derivation was limited to cultures passaged at about day 11 of differentiation (data not shown), suggesting a reduced patterning response at very high cell densities, as observed for hES cell-derived R-NS cells 8 . These data demonstrate a robust patterning response in Noggin/SB431542-treated neural progeny and derivation of © 2009 Nature America, Inc. All rights reserved. relevant neuron subtypes after short differentiation periods (B19 d), compared with 30-50 d when using stromal feedermediated induction protocols 3, 22 .
Recent publications have reported the reprogramming of human somatic cells into hiPS cells 1, 23, 24 . We wanted to next determine whether dual-SMAD inhibition could be used to reliably generate a broad repertoire of hiPS cell-derived neural cell types. Given the expected intrinsic variability among hiPS cell clones, reproducible differentiation results would confirm the robustness of our differentiation protocol. Two hiPS cell clones (iPS-14, iPS-27; Fig. 3a) were generated using lentiviral transduction of human fetal lung fibroblasts with cMYC, KLF4, OCT4 and SOX2. Both clones express the pluripotency markers including Nanog, Tra-1-60 and SSEA-3 at the undifferentiated state and are capable of differentiating into derivatives of the three germ layers (data not shown). Upon neural induction by means of the Noggin/SB431542 protocol, both clones yielded nearly homogeneous populations of PAX6 + cells by day 11 of differentiation ( Fig. 3b) . Using the strategies described above to manipulate cell density, passage and patterning factors, both hiPS cell clones could be readily biased toward generating HNK1 + putative neural crest progeny (Fig. 3c) , hiPS cell-derived R-NS cells (Fig. 3d) and specific hiPS cell-derived neuron subtypes, including somatic motoneurons (Fig. 3e ) and dopamine neurons (Fig. 3f ). These data demonstrate robustness and extension of the dual-SMAD-inhibition strategy beyond hES-cell differentiation. The protocol offers an efficient, defined and robust platform for the rapid generation of hiPS cellderived neural cell types.
In this report, we describe a method of neural differentiation that combines the inhibitors Noggin and SB431542 to block SMAD signaling. Noggin and SB431542 act on pluripotent cells at multiple stages of differentiation and provide access to an early intermediate progenitor capable of giving rise to known populations of R-NS and NCS cells (Fig. 4) . Whereas for most of the studies presented here an 11-d treatment period was used, preliminary studies indicate that similar levels of neural induction can be achieved when the treatment is shortened to the first 5 d of differentiation (Supplementary . Fig. 6 online; and data not shown). This should further reduce complexity and cost, particularly of recombinant Noggin. Noggin/SB431542 treatment greatly improves on current methods of generating neural tissue by inducing rapid and uniform neural conversion of human pluripotent cells under adherent culture conditions without the need for embryoid body formation or MS5 stromal feeder co-culture. The protocol allows for the derivation of relevant neuron subtypes after much shorter differentiation periods (B19 d) compared with 30-50 d of differentiation for stromal feeder-mediated induction protocols 3, 22 . Given the need for defined protocols that induce rapid and complete neural conversion, this technique may become the standard strategy for driving differentiation of human pluripotent cells.
METHODS
Cells and culture conditions. hES cell (WA-09; passages 35-45) and iPS lines (iPS-14, iPS-27; passages 4-10) were cultured on mouse embryonic fibroblasts plated at 12-15,000 cells/cm 2 (MEFs, Globalstem). A medium of DMEM/F12, 20% knockout serum replacement (Gibco), 0.1 mM b-mercaptoethanol, 6 ng/ml FGF-2 was changed daily. Cells were passaged using 6 U/ml of dispase in hES-cell media, washed and replated at a dilution of 1:5 to 1:10.
IPS cell generation. The cDNAs encoding hOct4, hSox2, hKlf4 and c-myc (Open Biosystems) were subcloned into self-inactivating lentiviral vectors driven by the human phosphoglycerate kinase (PGK) promoter. Lentiviral vector supernatants were produced by triple co-transfection of the plasmid DNA encoding the vector, pCMVDR8.91 and pUCMD.G into 293T cells.
Human fetal lung fibroblasts (MRC-5) purchased from ATCC (CCL-171) were seeded at 1.5 Â 10 4 cells/cm 2 in Eagle's Minimum Essential Medium supplemented with 10% FBS (FBS). The following day the fibroblasts were transduced with equal amounts of supernatants of the four lentiviral vectors in the presence of 4 mg/ml polybrene for B16 h. Six days after transduction, fibroblasts were harvested by trypsinization and plated at 2 Â 10 4 cells per 60 mm dish on a feeder layer of mytomycin C-treated mouse embryonic fibroblasts (CF-1). The next day, the medium was switched to hES-cell medium. The iPS lines were confirmed positive for Tra-1-81, Tra-1-60, SSEA-4 and Nanog by immunofluorescence and flow cytometry. In both hiPS cell clones, all four vector-encoded transgenes were found to be silenced.
Neural induction. hES-cell cultures were disaggregated using accutase for 20 min, washed using hES-cell media and pre-plated on gelatin for 1 h at 37 1C in the presence of ROCK inhibitor to remove MEFs. The nonadherent hES cells were washed and plated on Matrigel at a density of 10,000-25,000 cells/cm 2 on Matrigel (BD)-coated dishes in MEF conditioned hES-cell medium spiked with 10 ng/ml of FGF-2 and ROCK-inhibitor. Ideal cell density was found to be 18,000 cells/cm 2 . The ROCK inhibitor was withdrawn, and hES cells were allowed to expand in cell medium for 3 d or until they were nearly confluent. The initial differentiation media conditions included knockout serum replacement media with 10 mM TGF-b inhibitor (Tocris) and 500 ng/ml of Noggin (R&D). Upon day 5 of differentiation, the TGF-b inhibitor was withdrawn and increasing amounts of N2 media (25%, 50%, 75%) was added to the knockout serum replacement medium media every 2 d while maintaining 500 ng/ml of Noggin. For MS5 induction, established methods previously reported were used 22 .
Quantitative real-time PCR. Total RNA was extracted using an RNeasy kit (Qiagen). For each sample, 1 mg of total RNA was treated for DNA contamination and reverse transcribed using the Quantitect RT kit (Qiagen). Amplified material was detected using Quantitect SYBR green probes and PCR kit (Qiagen) on a Mastercycler RealPlex2 (Eppendorf). All results were normalized to a HPRT control and are from 4-6 technical replicates of 2-3 independent biological samples at each data point.
Neuronal patterning and differentiation. Dopaminergic patterning was initiated using BDNF, ascorbic acid, sonic hedgehog and FGF8 in N2 media as previously reported 22 , and maturation was performed in the presence of BDNF, ascorbic acid, GDNF, TGFb-1 and cyclic-AMP. Motoneuron patterning was performed using BDNF, ascorbic acid, sonic hedgehog and retinoic acid in N2 media as previously reported 18 .
